Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion

S J Gross1, M Stosic1, D M McDonald-McGinn2

  • 1Natera Inc, San Carlos, CA, USA.

Summary

This study evaluated a SNP-based non-invasive prenatal test (NIPT) for 22q11.2 deletion syndrome, finding a low positive predictive value but identifying cases in a referral population. Management resources are crucial for high-risk pregnancies.